Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Genome-wide covariation analysis sheds light on the evolution of SARS-CoV-2

Researchers in the United States have computed genome-wide covariation within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to investigate interactions that could be of considerable importance in the prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).

10 Mar 2021

Researchers shed light on T-cell receptor activation in response to infection

Immune cells specialize to ensure the most efficient defense against viruses and other pathogens. Researchers at the University of Basel have shed light on this specialization of T cells and shown that it occurs differently in the context of an acute and a chronic infection.

10 Mar 2021

Low doses of aspirin may have a potential beneficial effect on COVID-19

Aspirin is an established, safe, and low-cost medication in long-standing common use in prevention and treatment of cardiovascular diseases, and in the past a pain relief and fever reducing medication.

10 Mar 2021

Hydroxychloroquine has no effect in treating people with COVID-19, study shows

A year ago, infectious disease doctor Christine Johnston was leading a study on the use of hydroxychloroquine for the treatment of people with COVID-19.

10 Mar 2021

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

A team of scientists from the USA and Canada has recently characterized the antibodies developed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in response to an mRNA-based coronavirus disease 2019 (COVID-19) vaccine.

10 Mar 2021

For Covid ‘long haulers,’ battling for disability benefits adds aggravation to exhaustion

Rickie Andersen took a brief break from work in March after she fell ill. Her cough, fever and chills were typical covid-19 symptoms, but coronavirus tests were so scarce she could not obtain one to confirm the diagnosis.

10 Mar 2021

How likely is SARS-CoV-2 reinfection?

The coronavirus disease 2019 (COVID-19) pandemic has already caused over 117.6 million confirmed cases the world over. Yet, researchers debate the exact incidence of reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19’s causative pathogen.

10 Mar 2021

Delaying second doses of COVID-19 vaccines has benefits, but longer-term results rely on robust immunity

Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term.

10 Mar 2021

New study may lead to therapeutic strategies for chronic lung disease

Scientists at Washington University School of Medicine in St. Louis have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection.

10 Mar 2021

Researchers discover new COVID-19 variants in three South African provinces

Variants of the coronavirus are appearing in different parts of the world, many of them spreading with alarming speed.

10 Mar 2021

Cotton fabrics perform better in masks to slow the spread of COVID-19

Researchers have come up with a better way to test which fabrics work best for masks that are meant to slow the spread of COVID-19.

9 Mar 2021

Study finds reduction in pediatric emergency visits, hospitalizations during the pandemic

Amid the COVID-19 pandemic, children's hospitals across the United States have seen signification reductions in the number of children being treated for common pediatric illnesses like asthma and pneumonia, according to a new multicenter study led by Monroe Carell Jr. Children's Hospital at Vanderbilt.

9 Mar 2021

Optimized SARS-CoV-2 vaccine candidate could be less reactogenic, say researchers

A new study, released as a preprint on the bioRxiv* server, reports an optimized coronavirus disease 2019 (COVID-19) vaccine candidate, which, claim the researchers, may be less likely to produce reactions like fevers. It may also have increased protective potential against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen that causes COVID-19.

9 Mar 2021

Ultraviolet light therapy reduces viral load in critically ill COVID-19 patients

Scientists from the United States has recently evaluated the safety and efficacy profiles of ultraviolet-A (UVA) light applied via an endotracheal tube to critically ill COVID-19 patients.

9 Mar 2021

Speaking whilst infected with COVID-19 may cause it to spread

News-Medical speaks to Dr. Keiko Ishii about her research efforts during the COVID-19 pandemic and how speaking whilst infected can cause the virus to spread, and why wearing masks is so important.

9 Mar 2021

Current vaccines and therapies may be less effective at neutralizing new SARS-CoV-2 variants

A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.

8 Mar 2021

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

The currently developed vaccines against SARS-CoV-2 include the RBD in their immunogen. With a similar objective, a new study developed an RBD protein-based vaccine candidate against the SARS-CoV-2, using self-assembling Helicobacter pylori-bullfrog ferritin nanoparticles as an antigen delivery system. The study is published recently in the journal mBio (by the American Society of Microbiology).

8 Mar 2021

Five-day course of high-dose antibiotic will do just as well for children with pneumonia

Many parents know the struggle of having to make children with pneumonia finish the usual 10-day course in antibiotics despite the child feeling better after a few days of medication.

8 Mar 2021

Push is on for states to ban organ transplant discrimination

Griffin Dalrymple is an energetic 7-year-old who loves going to school in Eureka, Montana. But two years ago, the boy described by his mother, Jayci, as a "ball of fire" was suddenly knocked back by severe bacterial pneumonia that hospitalized him for two weeks.

8 Mar 2021

On vacci-dating: Singles seem enamored of sharing vaccination status online. Is that wise?

As cold weather descended upon Washington, D.C., last fall, I deleted my dating apps.

8 Mar 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Genome-wide covariation analysis sheds light on the evolution of SARS-CoV-2

Researchers shed light on T-cell receptor activation in response to infection

Low doses of aspirin may have a potential beneficial effect on COVID-19

Hydroxychloroquine has no effect in treating people with COVID-19, study shows

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

For Covid ‘long haulers,’ battling for disability benefits adds aggravation to exhaustion

How likely is SARS-CoV-2 reinfection?

Delaying second doses of COVID-19 vaccines has benefits, but longer-term results rely on robust immunity

New study may lead to therapeutic strategies for chronic lung disease

Researchers discover new COVID-19 variants in three South African provinces

Cotton fabrics perform better in masks to slow the spread of COVID-19

Study finds reduction in pediatric emergency visits, hospitalizations during the pandemic

Optimized SARS-CoV-2 vaccine candidate could be less reactogenic, say researchers

Ultraviolet light therapy reduces viral load in critically ill COVID-19 patients

Speaking whilst infected with COVID-19 may cause it to spread

Current vaccines and therapies may be less effective at neutralizing new SARS-CoV-2 variants

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

Five-day course of high-dose antibiotic will do just as well for children with pneumonia

Push is on for states to ban organ transplant discrimination

On vacci-dating: Singles seem enamored of sharing vaccination status online. Is that wise?

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in